Abstract

Irritable bowel syndrome (IBS) is one of the most difficult disorders to treat. It has a significant impact on quality of life, cost, and health. Ayurveda the board through entire framework approach in IBS is investigated. A randomized controlled parallel group study is the current trial. The study recruited 48 IBS patients between the ages of 20 and 60 who met the Rome IV criteria. Two groups of patients were randomly selected. The KC group intervened by giving three grams of Kalingadi churna twice daily, before meals, with buttermilk. With the whole system ayurveda protocol (WSAP), the WS group intervened. The intervention lasted for 60 days, with 15-day follow-ups. Various clinical measures, such as the IBS Symptom Severity Score and WSAP, were used to assess whether or not IBS (IBS constipation and IBS diarrhea) could be effectively managed. Abdominal pain, bowel consistency, frequency, and adequate relief all improved.